Julia Glade Bender - Concepedia

Author

Julia Glade Bender

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Amar Gajjar, J BENDER, J Bender, J G Bender, J GLADEBENDER, J L Glade Bender, J. Bender, J. G. Bender, J. Glade Bender, J. Glade-Bender

306

Publications

7.4K

Citations

H-Index

137

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Columbia University Irving Medical Center Children's Hospital of Philadelphia Harvard University Dana-Farber/Boston Children's Cancer and Blood Disorders Center

About

Julia Glade Bender is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	37	2.4K
2	Health Sciences	8	8	184
3	Natural Sciences	2	2	174
4	Public Health	2	2	59
5	Engineering	1	1	201

Julia Glade Bender

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren, The Lancet Oncology Interim AnalysisLymphoid NeoplasiaSurgical OncologyMedicineMelanoma	2019	324
Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial Rajen Mody, Arlene Naranjo, Collin Van Ryn, The Lancet Oncology Cog Anbl1221Neuro-oncologyGliomaMedicineNeurology	2017	268
Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study Julia Glade Bender, Peter C. Adamson, Joel M. Reid, Journal of Clinical Oncology	2008	248
Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial Andreas Bender, Walter Koch, Matthias Elstner, Neurology	2006	202
An overview of systems studies of automated highway systems Julia Glade Bender IEEE Transactions on Vehicular Technology EngineeringTransportation Systems ModelingIntelligent SystemsCandidate System ConceptsIntelligent Traffic Management	1991	201
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors Marian H. Harris, Steven G. DuBois, Julia Glade Bender, JAMA Oncology	2016	199
Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations Jennifer A. Oberg, Julia Glade Bender, Maria Luisa Sulis, Genome Medicine	2016	187
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets Benjamin A. Nacev, Francisco Sánchez-Vega, Shaleigh Smith, Nature Communications	2022	187
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children’s Oncology Group Rajen Mody, Alice L. Yu, Arlene Naranjo, Journal of Clinical Oncology	2020	181
CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to γ-secretase inhibitors Teresa Palomero, Kelly Barnes, Pedro J. Real, Leukemia Lymphoid NeoplasiaHigh SensitivityImmunologyImmune SurveillanceAberrant Notch1 Activation	2006	165

Page 1